Despite the initial identification of OSM as a tumor suppressor, a pro-inflammatory role of OSM has been reported in colon cancer, breast cancer, pancreatic cancer, myeloma, brain tumors, chronic lymphocytic leukemia, hepatoblastoma and COVID-191,3,8. Here, OSM is linked to breast carcinoma.